Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,038
+$1,116 QoQ
Shares Held
281
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,441
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALERUS FINANCIAL NA holds $65,318,341 across 13 Drug Manufacturers - General names. NVS ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,766 | $20,109,645 | |
| 2 | JNJ |
Johnson & Johnson
|
74,659 | $18,961,146 | |
| 3 | ABBV |
AbbVie Inc.
|
48,063 | $12,094,573 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,144 | $8,242,504 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,984 | $2,476,738 | |
| 6 | PFE |
Pfizer Inc
|
87,204 | $2,099,872 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,022 | $1,139,839 | |
| 8 | AZN |
Astrazeneca PLC
|
586 | $111,117 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,038 | 281 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $42,922 | 281 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $38,741 | 281 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,035 | 281 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $34,003 | 281 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||